• OPEN AN ACCOUNT
Indian Indices
Sensex
74,152.64 -675.61
( -0.90%)
Global Indices
Nasdaq
51,527.73 -356.96
(-0.69%)
Dow Jones
7,726.85 -58.79
(-0.76%)
Hang Seng
65,040.24 903.99
(1.41%)
Nikkei 225
10,716.75 8.42
(0.08%)
Forex
USD-INR
95.65 -0.17
(-0.17%)
EUR-INR
109.56 -0.37
(-0.34%)
GBP-INR
127.74 -0.44
(-0.34%)
JPY-INR
0.61 0.00
(-0.29%)

EQUITY - MARKET SCREENER

Gujarat Themis Biosyn Ltd
Industry :  Pharmaceuticals - Indian - Bulk Drugs
BSE Code
ISIN Demat
Book Value()
506879
INE942C01045
79.7352476
NSE Symbol
P/E(TTM)
Mar.Cap( Cr.)
GUJTHEM
109.64
5336.87
EPS(TTM)
Face Value()
Div & Yield %
3.74
1
0.14
 

Godfrey Phillips India consolidated net profit rises 86.71% in the March 2026 quarter
May 15,2026
Net profit of Godfrey Phillips India rose 86.71% to Rs 521.46 crore in the quarter ended March 2026 as against Rs 279.29 crore during the previous quarter ended March 2025. Sales rose 13.75% to Rs 1781.16 crore in the quarter ended March 2026 as against Rs 1565.82 crore during the previous quarter ended March 2025.

For the full year,net profit rose 42.35% to Rs 1526.06 crore in the year ended March 2026 as against Rs 1072.03 crore during the previous year ended March 2025. Sales rose 13.88% to Rs 6352.63 crore in the year ended March 2026 as against Rs 5578.46 crore during the previous year ended March 2025.

ParticularsQuarter EndedYear Ended
Mar. 2026Mar. 2025% Var.Mar. 2026Mar. 2025% Var.
Sales1781.161565.82 14 6352.635578.46 14
OPM %31.0317.18 -24.9421.11 -
PBDT701.01415.30 69 2060.811594.69 29
PBT668.40373.76 79 1939.861471.05 32
NP521.46279.29 87 1526.061072.03 42